343
Views
5
CrossRef citations to date
0
Altmetric
Patenting perspective

Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property

, , , , , & show all
Pages 115-130 | Received 15 Jul 2021, Accepted 14 Oct 2021, Published online: 01 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gabriel F. Martins & N. Galamba. (2023) Protein aggregation-inhibition: a therapeutic route from Parkinson’s disease to sickle cell anemia. Critical Reviews in Biochemistry and Molecular Biology 58:1, pages 50-80.
Read now

Articles from other publishers (4)

Glen E. Kellogg, Yana Cen, Malgorzata Dukat, Keith C. Ellis, Youzhong Guo, Jiong Li, Aaron E. May, Martin K. Safo, Shijun Zhang, Yan Zhang & Umesh R. Desai. (2023) Merging cultures and disciplines to create a drug discovery ecosystem at Virginia commonwealth university: Medicinal chemistry, structural biology, molecular and behavioral pharmacology and computational chemistry. SLAS Discovery.
Crossref
Xiaomeng Xu, Mohini S. Ghatge, Boshi Huang, Ahmed Alghamdi, Huiqun Wang, B. Daniel Pierce, Osheiza Abdulmalik, Yan Zhang, Martin K. Safo & Jürgen Venitz. (2023) Quantitative assessment of the in-vitro binding kinetics of antisickling aromatic aldehydes with hemoglobin A: A universal HPLC-UV/Vis method to quantitate Schiff-base adduct formation. Journal of Pharmaceutical and Biomedical Analysis 223, pages 115152.
Crossref
William A. Eaton. (2022) Drug discovery by a basic research scientist. Frontiers in Molecular Biosciences 9.
Crossref
Boshi Huang, Mohini S. Ghatge, Akua K. Donkor, Faik N. Musayev, Tanvi M. Deshpande, Mohammed Al-Awadh, Rana T. Alhashimi, Hongmei Zhu, Abdelsattar M. Omar, Marilyn J. Telen, Yan Zhang, Tim J. McMahon, Osheiza Abdulmalik & Martin K. Safo. (2022) Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease. Molecules 27:20, pages 6835.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.